GSK

News

GSK, Merck in endometrial cancer face-off

GSK and Merck & Co have both reported new clinical data with the PD-1 checkpoint inhibitors, seeking an edge in the first-line treatment of advanced endometrial cancer

News

GSK passes to Magic Johnson for RSV awareness drive

GSK said basketball legend will help spark “important conversations” about RSV in older adults.

News

GSK hits back in 5-in-1 meningitis jab contest with Pfizer

Phase 3 trial sets up filing for GSK's MenABCWY vaccine, several months later than its rival.

News

Mersana stung by FDA hold on STING drug

Death in ph1 trial casts a pall over GSK-backed project, licensed for $100m upfront last year.

News

GSK wins the vote contest in FDA’s RSV vaccine panels

Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.

News

Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn

There was debate about cases of Guillain Barré and the population of the phase 3 RENOIR trial.

GSK, Merck in endometrial cancer face-off

GSK passes to Magic Johnson for RSV awareness drive

GSK hits back in 5-in-1 meningitis jab contest with Pfizer

Mersana stung by FDA hold on STING drug

GSK wins the vote contest in FDA’s RSV vaccine panels

Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn

Roche, Viking, and Syntis showcase obesity drug candidates

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks